Perpetuum Ventures

Foundation date

18/01/2018

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

PIONEERING PLANT SCIENCE.

Perpetuum is a biotech company that develops safe, sustainable plant-based therapeutics for the effective management and improvement of healthspan of people.

Our company focuses on four R&D platforms:

  • Plant cell extraction

  • Transient expression of recombinant proteins in plants

  • Dendritic nano adjuvants

  • Biopolymer scaffolds

Upcoming events

Latest news

  • UCB announces positive Phase 3 studies for bimekizumab in hidradenitis suppurativa

    1 day ago

  • Company growth prompts Connected-Pathology relocation to larger laboratory facilities to accommodate increase in study capacity

    Tuesday December 6th 2022

  • Japan welcomes companies, startups and knowledge institutions from Flanders

    Friday December 2nd 2022